Authors

Subscribe:.rss.atom.json.md

Publishes 3 feeds

• All News

  All News

  10 posts · contributor

• FDA News: Approvals, Adcomms, Complete Response Letters and Guidances

  FDA News: Approvals, Adcomms, Complete Response Letters and Guidances

  10 posts · contributor

• Podcasts

  Podcasts

  5 posts · contributor

Lately

• Roche pours $750M into Oregon manufacturing plant as obesity push expands

  All News · 2026-08-20

• Scribe’s early-stage IPO standout defies biotech’s derisking trend

  All News · 2026-08-20

• Regeneron wins FDA approval to challenge Ipsen for rare bone disease market

  FDA News: Approvals, Adcomms, Complete Response Letters and Guidances · 2026-08-20

• Regeneron wins FDA approval to challenge Ipsen for rare bone disease market

  All News · 2026-08-20

• Ultragenyx bags first gene therapy approval as previously rejected Sanfilippo asset awaits decision

  FDA News: Approvals, Adcomms, Complete Response Letters and Guidances · 2026-08-20

• Ultragenyx bags first gene therapy approval as previously rejected Sanfilippo asset awaits decision

  All News · 2026-08-20

• Merck’s Moderna-partnered vaccine success clears view of post-Keytruda future

  All News · 2026-08-20

• Rewriting the rules of CMV prevention

  All News · 2026-08-20

• 7 biopharma M&A deals where layoffs followed

  All News · 2026-08-20

• Out of sight, out of work? What’s driving remote job cuts

  All News · 2026-08-20

• Why pediatric rare oncology outperforms in a volatile biotech market

  FDA News: Approvals, Adcomms, Complete Response Letters and Guidances · 2026-08-20

• Why pediatric rare oncology outperforms in a volatile biotech market

  All News · 2026-08-20

Everything on this page was read from markup Heather McKenzie published — a rel="me" link, an h-card, or the feed’s own author element. Nothing was inferred from anywhere else. To correct or remove it, get in touch. Machine-readable: JSON